Elecsys Blood Test Gains EU Approval, FDA Expands Fremanezumab Indication Into Pediatrics, VX-993 Fails Phase 2 Pain Trial
Neurology News Network. for the week ending August 9, 2025. [WATCH TIME: 4 minutes]
Previous Post
CDC shaken after gunman attacks its headquarters
Next Post
Why Human Oversight Matters When Implementing AI in Diabetes Care: Marry Vuong, PharmD, BCPPS
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago